These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36706492)

  • 1. In-vitro cytotoxicity and in-vivo antitumor activity of two platinum complexes with 1,3-dimethyl pentyl glycine ligand against breast cancer.
    Bazsefidpar P; Eftekhar E; Jahromi MZ; Nikpoor AR; Moghadam ME; Zolghadri S
    J Inorg Biochem; 2023 Apr; 241():112144. PubMed ID: 36706492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two new oral candidates as anticancer platinum complexes of 1,3-dimethyl pentyl glycine ligand as doping agents against breast cancer.
    Ramezani N; Eslami Moghadam M; Behzad M; Zolghadri S
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119415. PubMed ID: 33497975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer.
    Kadivar D; Eslami Moghadam M; Notash B
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Dec; 322():124809. PubMed ID: 39018672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some new anticancer platinum complexes of dithiocarbamate derivatives against human colorectal and pancreatic cell lines.
    Hosseinzadeh S; Eslami Moghadam M; Sheshmani S; Shahvelayati AS
    J Biomol Struct Dyn; 2020 May; 38(8):2215-2228. PubMed ID: 31204612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-bioactivity relationship study on anticancer Pd and Pt complexes with aliphatic glycine derivative ligands.
    Hosseini-Hashemi Z; Eslami Moghadam M; Notash B; Mirzaei M
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Sep; 317():124408. PubMed ID: 38723464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anticancer Pd and Pt complexes of tertamyl dithiocarbamate and DACH ligands against HT29 and Panc1 cell lines.
    Hosseinzadeh S; Eslami Moghadam M; Sheshmani S; Shahvelayati AS
    J Biomol Struct Dyn; 2022 Sep; 40(15):6910-6920. PubMed ID: 33645454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model.
    Luo FR; Wyrick SD; Chaney SG
    Cancer Chemother Pharmacol; 1999; 44(1):29-38. PubMed ID: 10367746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
    Yu CW; Li KK; Pang SK; Au-Yeung SC; Ho YP
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1686-91. PubMed ID: 16386904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.
    Shams Abyaneh FS; Eslami Moghadam M; Divsalar A; Ajloo D; Hosaini Sadr M
    Appl Biochem Biotechnol; 2018 Oct; 186(2):271-291. PubMed ID: 29516403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Property evaluation of two anticancer candidate platinum complexes with N-isobutyl glycine ligand against human colon cancer.
    Hosseini Hashemi Z; Mirzaei M; Eslami Moghadam M
    Biometals; 2022 Oct; 35(5):987-1009. PubMed ID: 35829930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability.
    M M; Chhatar S; Gadre S; Paul S; Vaidya SP; Khatri S; Duari P; Kode J; Ingle A; Kolthur-Seetharam U; Patra M
    Chemistry; 2024 Jan; 30(4):e202302720. PubMed ID: 37888749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Effect of Pt
    Elias MG; Fatima S; Mann TJ; Karan S; Mikhael M; de Souza P; Gordon CP; Scott KF; Aldrich-Wright JR
    Cancers (Basel); 2024 Jul; 16(14):. PubMed ID: 39061185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and biological features of platinum (II) complexes with 3-hydroxy-3-(Trifluoromethyl)cyclobutane-1,1-Dicarboxylate as a leaving ligand.
    Liu F; Yang C; Li S; Wu X; Xue K; Zhou Y; Liang X; Cheng X; Shi Q; Su W
    Eur J Med Chem; 2022 Nov; 242():114673. PubMed ID: 36049275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
    J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
    Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
    Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
    Hajipour F; Mahdavinia M; Fereidoonnezhad M
    Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.